Development of resistance of human immunodeficiency virus (HIV) to anti-HIV agents: how to prevent the problem?
- 30 June 1997
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 9 (1) , 21-36
- https://doi.org/10.1016/s0924-8579(97)00031-9
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Multiple Drug Resistance to Nucleoside Analogues and Nonnucleoside Reverse Transcriptase Inhibitors in an Efficiently Replicating Human Immunodeficiency Virus Type 1 Patient StrainThe Journal of Infectious Diseases, 1996
- In vitro selection and molecular characterization of human immunodeficiency virus type 1 with reduced sensitivity to 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA)Antiviral Research, 1996
- Phase 1 Study of Combination Therapy with L-697,661 and ZidovudineJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Complete inhibition of viral breakthrough by combination of MKC-442 with AZT during a long-term culture of HIV-1-infected cellsAntiviral Research, 1996
- In Vivo Resistance to a Human Immunodeficiency Virus Type 1 Proteinase Inhibitor: Mutations, Kinetics, and FrequenciesThe Journal of Infectious Diseases, 1996
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- A Pilot Study to Evaluate the Development of Resistance to Nevirapine in Asymptomatic Human Immunodeficiency Virus-Infected Patients with CD4 Cell Counts of >500/mm3 : AIDS Clinical Trials Group Protocol 208The Journal of Infectious Diseases, 1995
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995